Mallinckrodt raises guidance after fiscal Q3 results

Mallinckrodt (MNK -1.7%) fiscal Q3 results: Net Sales: $653.1M (+14.6%); Gross Profit: $284.3M (+7.0%); Operating Loss: ($4.4M) (-633.3%); Net Loss: ($24.1M) (+13.6%); Loss Per Share: ($0.41) (+14.6%); Quick Assets: $327.9M (+19.0%): CF Ops (9 mo.): $168.1M (+999%).

Fiscal 2014 Guidance: Net sales: $2.35B from $2.45B from $2.28 - 2.38B; Specialty Pharma sales: $1.425B - 1.500B from $1.38B - 1.43B; Global Medical Imaging sales: $850M - 900M (unch); Methylphenidate sales: at least $190M from at least $160M; non-GAAP EPS: $4.00 - 4.30 from $3.30 - 3.60.

This was corrected on 08/07/2014 at 08:48 AM.
From other sites
Comments (7)
  • sunwindgeo
    , contributor
    Comments (856) | Send Message
    This is what is so frustrating about the internet, 'news outlets' on stocks. Market Watch is reporting that Mallinckrodt raised its guidance. You are saying here that:
    Mallinckrodt lowers guidance after fiscal Q3 results


    Which one is right?



    "Mallinckrodt PLC said its full-year results are looking "promising" as the company posted a narrower fiscal third-quarter loss amid a surge in specialty pharmaceutical revenue.


    The company boosted its full-year adjusted earnings guidance by 70 cents to $4 to $4.30, while raising its revenue outlook to $2.35 billion to $2.45 billion from the previous range of $2.28 billion to $2.38 billion. "
    7 Aug 2014, 07:37 AM Reply Like
  • SludgeReports
    , contributor
    Comments (70) | Send Message
    The correct response is... SA Market Currents continuously posts incorrect statements about QCOR and now MNK. So what's new?


    How many times have folks had to comment on SA Market Current inaccuracies before SA either fires that editor or that editor learns to read better and/or proofs his posts before posting.
    7 Aug 2014, 08:38 AM Reply Like
  • drdon
    , contributor
    Comments (215) | Send Message
    Here is the company's statement. SA editors you need to get your act together. You keep losing credibility..


    Looking ahead, the company now expects adjusted earnings per share in the range of $4.00 - $4.30, up from the prior range of $3.30 - $3.60. Revenue forecast was raised to $2.35 billion - $2.45 billion, from the previous forecast of $2.28 billion - $2.38 billion. Analysts expect earnings per share of $3.53 on revenues of $2.38 billion.
    7 Aug 2014, 08:52 AM Reply Like
  • azeemh
    , contributor
    Comments (2) | Send Message
    This is WRONG. It is the opposite. They have RAISED the guidance. Read the press release again. The numbers are a beat.
    7 Aug 2014, 09:55 AM Reply Like
  • User 13931022
    , contributor
    Comment (1) | Send Message
    It was a revision upwards. The "revised" guidance referenced here was the May guidance. August guidance was revised upwards.
    7 Aug 2014, 09:55 AM Reply Like
    , contributor
    Comment (1) | Send Message
    Whoever wrote this comment got his numbers backward. Raised guidance. The author should remove this or make a correction. Always read the results that the company reports not paid bashers.
    7 Aug 2014, 09:55 AM Reply Like
  • lewdude12
    , contributor
    Comment (1) | Send Message
    SA is just part ot the community shorting this stock even though their performance is consistently above average, way above average much better than SA.
    7 Aug 2014, 11:03 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs